tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Ratios

Compare
0 Followers

KalVista Pharmaceuticals Ratios

DE:4XC1's free cash flow for Q2 2026 was $0.91. For the 2026 fiscal year, DE:4XC1's free cash flow was decreased by $ and operating cash flow was $-3.11. See a summary of the company’s cash flow.
Ratios
TTM
Apr 25Apr 24Apr 23Apr 22
Liquidity Ratios
Current Ratio
7.22 5.35 9.90 11.46 16.73
Quick Ratio
7.21 5.35 9.90 11.46 16.73
Cash Ratio
5.40 2.18 1.39 3.74 2.65
Solvency Ratio
-0.65 -1.17 -4.37 -4.16 -4.35
Operating Cash Flow Ratio
-3.56 -3.39 -3.91 -5.01 -6.75
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 2.29M$ 86.31M$ 196.87M$ 150.15M$ 174.86M
Leverage Ratios
Debt-to-Assets Ratio
0.44 0.03 0.03 0.04 0.04
Debt-to-Equity Ratio
8.80 0.07 0.04 0.05 0.04
Debt-to-Capital Ratio
0.90 0.06 0.03 0.05 0.04
Long-Term Debt-to-Capital Ratio
0.89 0.00 0.00 0.00 0.00
Financial Leverage Ratio
20.00 2.63 1.14 1.14 1.10
Debt Service Coverage Ratio
-14.22 -30.55 0.00 0.00 0.00
Interest Coverage Ratio
-14.44 -32.50 0.00 0.00 0.00
Debt to Market Cap
0.17 0.00 0.00 0.00 0.00
Interest Debt Per Share
3.04 0.24 0.20 0.30 0.33
Net Debt to EBITDA
0.49 0.53 0.18 0.51 0.28
Profitability Margins
Gross Profit Margin
-17.16%0.00%0.00%0.00%0.00%
EBIT Margin
-1279.50%0.00%0.00%0.00%0.00%
EBITDA Margin
-1272.15%0.00%0.00%0.00%0.00%
Operating Profit Margin
-1342.96%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-1340.17%0.00%0.00%0.00%0.00%
Net Profit Margin
-1391.14%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-1391.14%0.00%0.00%0.00%0.00%
Net Income Per EBT
103.80%101.88%93.74%100.00%100.00%
EBT Per EBIT
99.79%95.77%96.19%83.80%85.23%
Return on Assets (ROA)
-61.87%-73.15%-53.80%-50.71%-40.39%
Return on Equity (ROE)
-282.01%-192.31%-61.30%-57.70%-44.49%
Return on Capital Employed (ROCE)
-68.86%-91.44%-66.06%-65.93%-50.24%
Return on Invested Capital (ROIC)
-68.52%-90.57%-61.55%-65.50%-49.99%
Return on Tangible Assets
-61.87%-73.15%-53.80%-50.71%-40.39%
Earnings Yield
-23.76%-26.83%-30.33%-37.55%-26.43%
Efficiency Ratios
Receivables Turnover
2.12 0.00 0.00 0.00 0.00
Payables Turnover
2.19 0.00 9.46 0.00 0.00
Inventory Turnover
38.67 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.23 0.00 0.00 0.00 0.00
Asset Turnover
0.04 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.07 0.00 0.00 0.00 0.00
Cash Conversion Cycle
15.01 0.00 -38.58 0.00 0.00
Days of Sales Outstanding
171.95 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
9.44 0.00 0.00 0.00 0.00
Days of Payables Outstanding
166.38 0.00 38.58 0.00 0.00
Operating Cycle
181.39 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-2.97 -3.08 -2.43 -2.70 -3.19
Free Cash Flow Per Share
-2.98 -3.09 -2.44 -2.74 -3.23
CapEx Per Share
<0.01 <0.01 0.01 0.04 0.04
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
-1.76K -352.32 -201.42 -62.93 -83.92
Capital Expenditure Coverage Ratio
-1.76K -352.32 -201.42 -62.93 -83.92
Operating Cash Flow Coverage Ratio
-1.07 -24.24 -12.20 -9.14 -9.54
Operating Cash Flow to Sales Ratio
-10.60 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-19.30%-22.43%-21.48%-30.91%-25.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.21 -3.73 -3.30 -2.66 -3.78
Price-to-Sales (P/S) Ratio
54.93 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
52.08 7.17 2.02 1.54 1.68
Price-to-Free Cash Flow (P/FCF) Ratio
-5.18 -4.46 -4.66 -3.24 -3.94
Price-to-Operating Cash Flow Ratio
-5.53 -4.47 -4.68 -3.29 -3.99
Price-to-Earnings Growth (PEG) Ratio
16.84 -0.51 -1.00 2.98 -0.09
Price-to-Fair Value
52.08 7.17 2.02 1.54 1.68
Enterprise Value Multiple
-3.83 -3.41 -2.93 -2.11 -3.58
Enterprise Value
736.56M 591.38M 393.06M 199.39M 289.00M
EV to EBITDA
-3.83 -3.41 -2.93 -2.11 -3.58
EV to Sales
48.72 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-4.59 -3.86 -4.38 -2.61 -3.66
EV to Operating Cash Flow
-4.60 -3.87 -4.40 -2.65 -3.70
Tangible Book Value Per Share
0.32 1.92 5.62 5.77 7.56
Shareholders’ Equity Per Share
0.32 1.92 5.62 5.77 7.56
Tax and Other Ratios
Effective Tax Rate
-0.04 -0.02 0.06 0.00 0.00
Revenue Per Share
0.28 0.00 0.00 0.00 0.00
Net Income Per Share
-3.90 -3.69 -3.44 -3.33 -3.36
Tax Burden
1.04 1.02 0.94 1.00 1.00
Interest Burden
1.05 1.03 1.00 0.98 1.01
Research & Development to Revenue
3.68 0.00 0.00 0.00 0.00
SG&A to Revenue
10.63 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.37 0.00 0.00 0.00 0.00
Income Quality
0.76 0.83 0.70 0.81 0.95
Currency in USD